Clinical Trials Directory

Trials / Completed

CompletedNCT03205072

POCS in Liver Transplantation Patients

Per-Oral Cholangioscopy in Liver Transplantation Patients

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective, multi-center, non-randomized, observational, consecutive case series, which will compare Endoscopic Retrograde Cholangiopancreatoscopy (ERCP) and cholangioscopy with Spy Glass Digital System (DS) procedure at 5-10 centers.

Detailed description

The objective of this study is to demonstrate the clinical utility of cholangioscopy with Spy Glass Digital System (DS) in cadaveric donor or live donor liver transplantation patients who are referred for ERCP in the setting of a clinical suspicion of post liver transplant bile duct stricture(s). A secondary study objective is to generate a hypothesis for a randomized controlled trial comparing ERCP alone to ERCP with Per- Oral Cholangioscopy (POCS) in patients referred for ERCP post liver transplantation.

Conditions

Interventions

TypeNameDescription
DEVICESpy Glass DSThe SpyScope™ DS Access and Delivery Catheter (SpyScope™ DS Catheter) is a sterile, single-use endoscope that enables access and delivery of accessories to targeted pancreaticobiliary anatomy and displays live video when connected to a Spy Glass DS Digital Controller.

Timeline

Start date
2018-01-25
Primary completion
2022-03-24
Completion
2022-03-24
First posted
2017-07-02
Last updated
2022-07-28

Locations

5 sites across 4 countries: United States, Brazil, Netherlands, Spain

Regulatory

Source: ClinicalTrials.gov record NCT03205072. Inclusion in this directory is not an endorsement.